Regenerative Medical Technology Group Inc.
RMTG
$0.04
$0.003.00%
OTC PK
| 03/31/2026 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -- | -36.23% | 64.62% | 64.62% | 56.83% |
| Total Depreciation and Amortization | -- | -55.14% | -52.82% | -52.82% | -40.68% |
| Total Amortization of Deferred Charges | -- | -79.88% | -96.42% | -96.42% | -66.80% |
| Total Other Non-Cash Items | -- | 127.70% | -99.92% | -99.92% | -99.92% |
| Change in Net Operating Assets | -- | 42.05% | -9.81% | -9.81% | 9.58% |
| Cash from Operations | -- | -182.67% | -37.86% | -37.86% | 351.51% |
| Capital Expenditure | -- | 14.26% | 56.04% | 56.04% | 64.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 14.26% | 56.04% | 56.04% | 64.42% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 466.67% | 466.67% | 466.67% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | 213.52% | 263.97% | 263.97% | 160.87% |